Commitment to research
National and European projects
The French Institute of Bioinformatics contributes to or coordinates national and European scientific projects through PIA, PEPR, and other French funding sources, as well as through its participation in European projects via Elixir and the development of bioinformatics infrastructure.
This participation demonstrates its commitment to infrastructure development and scientific research in Biology and Health.
Acknowledgments and Affiliation
Acknowledgments and affiliations for each project can be found in the dedicated section.
Submit project-related publications to HAL, as required.

ABBA
The Advanced Bioinformatics for Biological Applications (ABBA, €1.6 million) project aims to complement the IT equipment funded by the PIA3 MUDIS4LS project.
ABRomics
Antibiotic resistance, i.e. the ability of bacteria to resist antibiotic treatments, is a major global health problem. Faced with this challenge, the ABRomics project, co-led by the IFB and the Institut Pasteur, and supported by the PPR Antibiotic Resistance, is dedicated to the development of an online community platform to strengthen surveillance and research on antibiotic resistance, as part of a One Health approach.
AgroServ
Integrated Services Supporting a Sustainable Agroecological Transition (AgroServ) will facilitate a systemic and holistic approach to understanding the threats and challenges facing agriculture in implementing a resilient and sustainable agri-food system
BYTE-SEA
The field of genomics has undergone a major revolution over the past 20 years, providing new insights into the biological and biochemical diversity of life. The declining cost of DNA sequencing has enabled the launch of ambitious new analysis programs and the discovery of new biological species. In the field of marine science, exploring diversity represents a major challenge, as only about 10% of marine species are known and only about 100 high-quality genomes of marine organisms have been made available to the scientific community.
Cloud4SAMS
The Cloud4SAMS targeted project aims to deploy a distributed digital infrastructure enabling researchers to exploit microbiome and health data in a secure computing environment. The PEPR SAMS is coordinated by Inserm and INRAE, and the Cloud4SAMS project is led by IFB-core. This project draws on the expertise of INRIA for the computing aspects, and of several Inserm, INRAE, and university laboratories for the production, analysis, and interpretation of microbiome data.
ELIXIR FAIRyMAGs
ELIXIR FAIRyMAGs aims to advance metagenomic research by developing, optimizing and disseminating FAIR (Findable, Accessible, Interoperable, Reusable) workflows dedicated to the construction of MAG (Metagenome-Assembled Genomes).
ELIXIR HARVEST
ELIXIR HARVEST aims to optimize existing resources by relying on recognized data standards (MIAPPE, ISA, ARC, RO-Crate) to facilitate access and reuse of plant data.
ELIXIR INTOXICOM
Recognizing the importance of toxicology, ELIXIR has created a community dedicated to this discipline. Its objective is to align FAIR solutions and open data from toxicology with ELIXIR services and resources. To do this, existing open solutions for integrating toxicological data will be disseminated.
ELIXIR Metabolomics
The ELIXIR tools platform aims to maintain and expand its services to facilitate the search, accessibility, interoperability and reusability of IT tools in order to meet the needs of the ELIXIR 2024-2028 program.
ELIXIR STEERS
The objective of ELIXIR-STEERS is to enable users across the European Research Area to access federated data and perform large-scale cross-border analyses in the field of life sciences.
ELIXIR Technology Tools
The ELIXIR tools platform aims to maintain and expand its services to facilitate the search, accessibility, interoperability and reusability of IT tools in order to meet the needs of the ELIXIR 2024-2028 program.
EOSC4cancer
EOSC4Cancer brings together comprehensive cancer centers, research infrastructures, leading research groups and major computing infrastructures across Europe to enable the exploitation of large cancer datasets.
- 1
- 2
